netFormulary NHS
Norfolk and Waveney
Formulary
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
06.01.04  Expand sub section  Treatment of hypoglycaemia
 note 

Managing an acute episode of hypoglycaemia (CKS)

Hypoglycaemia (a blood glucose level less than 3.5 mmol/L) is an inevitable adverse effect of insulin therapy. The absolute blood glucose level at which signs and symptoms begin to occur can vary between people.

Hypoglycaemia should be treated as soon as it is recognised, either by symptoms or by a blood glucose test. If the blood glucose is >4 mmol/l with symptoms, then a small snack may be taken, e.g. an apple, a small banana, a biscuit. If it is not possible to test, often the person's experience tells them they do not have sufficient time to test, then treatment should be given immediately.

If the person is able to swallow:

  • Children and young people should be given approximately 0.3 g/kg of a fast-acting carbohydrate.
  • Adults should promptly consume 10–20 g of a fast-acting carbohydrate, preferably in liquid form.
  • Examples include:
    • 5 glucose tablets; 6 dextrose tablets;
    • 200 mL (small carton) of fresh fruit juice (not sugar-free or reduced-sugar);
    • 3–4 heaped teaspoonfuls of sugar added to a cup of water;
    • 4 large jelly babies or 7 large jelly beans; 
    • 2 tubes of glucose 40% gel
  • Note: advise to avoid chocolates and biscuits as they have a lower sugar content, and their high fat content may delay stomach emptying.
  • Advise to recheck blood glucose levels after 10–15 minutes.
    • Hypoglycaemia should be reversed in about 10 minutes.
    • Improvements in clinical signs and symptoms may lag behind improvement in blood glucose level. 
  • If there is no response or an inadequate response, repeat oral intake as above, and re-test blood glucose levels after another 15 minutes.
  • When symptoms improve or normal blood glucose is restored, advise on the need for longer-acting carbohydrate to maintain blood glucose levels and prevent recurrence of hypoglycaemia. 
    • If the next meal is due, it should contain carbohydrate such as bread, potatoes, or pasta.
    • If the next meal is not due soon, the person should consume a carbohydrate-containing snack such as a sandwich, two plain biscuits, or a banana.
  • The Diabetes UK patient resource Having a hypo may be useful. 

If the person is unable to swallow or is unconscious:

  • IM glucagon should be administered immediately
    • For children younger than 8 years of age (or body weight less than 25 kg), 500 micrograms of glucagon should be given.
    • For all other people, 1 mg of glucagon should be given.
  • If the person does not respond to glucagon treatment within 10 minutes, emergency 999 transfer to hospital should be arranged for treatment with IV glucose
  • If the person responds to glucagon treatment within 10 minutes and is sufficiently alert and able to swallow safely, advise them to eat some oral carbohydrate (to replace the body's supply and to prevent relapse of hypoglycaemia)
Glucagon (GlucaGen® HypoKit)
(IM injection)
View adult BNF View SPC online View childrens BNF
Formulary
Green

1 unit of glucagon = 1 mg of glucagon

Patients should have 2 packs available for their use

 

Branded Ogluo® is non-formulary and has been given a Black classification pending formulary application.  It is not commissioned for use in Norfolk and Waveney

 

 
 
Glucose 40% oral gel (Hypoglycaemia)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Green

Issue only when the patient is unable to take glucose-containing products which are available to purchase.

Follow instructions for administration carefully.

 
 
06.01.04  Expand sub section  Chronic hypoglycaemia
Diazoxide (Chronic hypoglycaemia)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red Hospital

Eudemine tablets are on the hospital formulary but have not yet been considered for prescribing in primary care

Proglycem 25mg capsules are an unlicensed import - no agreed NHS price

 
 
 ....
 Non Formulary Items
Lift products (including juice shots and chew tablets)  ((previously Glucojuice))

View adult BNF View SPC online View SMC online View childrens BNF
Non Formulary
Black

hypoglycaemia   

BlackNHSE
Not commissioned.  No NHS prescribing in primary or secondary care  



  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG
Green Low Carbon

Low carbon footprint

Amber Medium Carbon

Medium carbon footprint

Red High carbon footprint

High carbon footprint

Traffic Light Status Information

Status Description

Green

Formulary - Drugs that can be initiated by Prescriber in Primary Care.  

Advice

Formulary - Specialist advice required from primary or secondary care clinician with relevant expertise prior to primary care initiation. Treatment can be initiated in primary care following advice or recommendation from clinician in primary or secondary care with relevant expertise  

Amber

Shared Care Agreement Level 0 - Prescribe the drug and perform a basic level of monitoring e.g. an annual review / administration  

Amber 1

Shared Care Agreement Level 1 - Prescribe the drug and perform a higher level of monitoring e.g. 6 monthly  

Amber 2

Shared Care Agreement Level 2 - Prescribe the drug and perform a more intense level of monitoring e.g. quarterly  

Amber 3

Shared Care Agreement Level 3 - Prescribe the drug and perform significant monitoring including measurements such as height, weight, blood pressure and ECG. Drugs requiring monthly monitoring fall into this category.  

Mixed

Drugs that have more than one traffic light classification.   

Red Hospital

Restricted use – Prescribing to remain with the hospital or specialist service. No prescribing in primary care   

Double Red

Not recommended for routine use. To be used only as a last resort in exceptional circumstances such as transfer of care, patient moving from out of area or where other treatment or pathway options have been exhausted. Seek advice from Medicines Optimisation Team where appropriate. Some items may require formal approval via the IFR process.   

Black

Not commissioned. No NHS prescribing in primary or secondary care  

Blue

NWICB are committed to fund positive NICE TA treatments. Awaiting clarification of place in pathway and commissioning arrangements. Further guidance will be issued when available. For all other treatments, formulary application and discussion will be required  

Switch

Not recommended for prescribing. Switch to cost-effective alternative  

Non Formulary

Non-formulary  

OTC

Available to buy over the counter. Consider self-care  

Yellow

Drugs that are commissioned by Public Health England/other health and social care departments eg Norfolk County Council - Specialist Prescribing Only. Not for GP prescribing  

Discontinued Medicines

Discontinued Medicines. This category will be under constant review and updated regularly  

netFormulary